AKD PHARMA LIMITED
Opportunity 72/100 (strong), bankability 65/100. Strong seller-intent signal (78/100, director aged 66). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Confirmation statement overdue. Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-04-05 | 2024-04-05 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
Corporate timeline (19 events)Click to expand
- 2026-01-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-10-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-01-05📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-01-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-01-04📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-04-01📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-01-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-01-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-12-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2016-12-23📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-05-04📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-12-18📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-05-07📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-12-02📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2014-05-19📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2013-12-20📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2007-04-19🏢Company incorporatedAs AKD PHARMA LIMITED
- 2007-04-19➕COYLE, Karen appointedsecretary
- 2007-04-19➕COYLE, Anthony appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 19 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 66 — succession pressure is live.
- +No director turnover: Company is 19 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 63+: Senior director is approximately 66. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 19 years.
- secondaryStable-but-static management: Company is 19 years old and no new directors in the last 3 years — succession not yet being planned internally.
Red flags
1 high ·Annual confirmation statement not filed on time. Required statutory filing — overdue is a strong discipline signal.
Evidence: Next due: 2026-05-03
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Anthony Coyle Individual · British · DOB 05/1960 · age 66 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 19/04/2017 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Manufacturing · L postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A.SMITH JOINERY LTD→ 14678106 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ALLROUND FABRICATIONS LIMITED→ 05636868 · est 2005 · no financials extracted | — | — | — | — | 20y | — | — |
| ALTAR POTTERY LTD→ 14741524 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| AMEA SERVICES UK LTD→ 12317921 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AMES GOLDSMITH U.K. LIMITED→ 05951718 · est 2006 · no financials extracted | — | — | — | — | 19y | — | — |
| AMOR CANDLES LTD→ 15596587 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANFIELD MARBLE & GRANITE LTD→ 13727616 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ANG ENGINEERING (UK) LIMITED→ 07961978 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| ANGEL JASON CREATIVE COMPANY LIMITED→ 13815881 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ANIEKPENO FASHION LIMITED→ 14469141 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ANSONG ASKEW LTD→ 12662446 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ANTI SPIKE STRAW LTD→ 13890495 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
9 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.